Advertisment
|
|
news roundup
LabCorp will acquire Chiltern, upon agreement with shareholders, for $1.2 billion and will become part of the LabCorp’s Covance segment. The addition grows the CRO capabilities of the organization.
| advertisment
15th Annual Global Forum
Sept 25-29, 2017
Hyatt Regency McCormick Place, Chicago, IL
Returning for its 15th iteration, the world's largest event for temperature-controlled life science supply chains heads back to Chicago this year with a focus on the next generation of temperature control! Join 850+ attendees from 30+ countries for five days of master classes, workshops, track sessions, panel discussions, roundtables, and more. With the Global Forum, your company will meet emerging and ongoing challenges for 2017 and beyond.
 Register now |
ICON has acquired Mapi Group to build on its existing commercialization and outcomes research business. Mapi Group’s capabilities include access to COA tools and instruments and real-world data sets.
| advertisment |
|
About Bridging Clinical Research and Clinical Health Care Collaborative
The Bridging Clinical Research and Clinical Health Care Collaborative is sponsored by SCORR Events, a division of SCORR Marketing, the leading marketing and communications firm in the health science industry. SCORR Events was established to provide education, collaboration and opportunities for industry professionals to advance health sciences.  Learn more
|
The European Medicines Agency (EMA) has published new guidance on first-in-human clinical trials, which takes into account trial protocol complexity, including different parts within a single clinical trial protocol, aimed at assessing for example single and multiple ascending doses, food interactions, or different age groups, according to the agency.
Novartis has signed an agreement contracting Cryoport—provider of logistics solutions for biopharmaceutical, IVF, and animal health organizations globally—over an initial three-year term for cryogenic logistics support of CTL019/CD19 CAR-T cell therapy.
|
|
|
advertisment
 
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
An investigator offers his take on on important considerations for creating the perfect protocol, as well as safety, logistics and selecting the right team.
| advertisment
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
Live Webcast: Tuesday, September 19 at 2:00pm BST and Thursday, September 28 at 10am EDT
 Register now |
There is increasing evidence that taking clinical trials to the patient’s home can improve standard of care, patient recruitment, patient retention and, in some cases, decrease costs. This article will look at evidence from patient care and clinical trials, and evaluate if homecare can be a driver of cost savings in a clinical study.
|
|
|
Blog Posts
Tanya Bridges and Donna Benson, from two non-affiliated study sites, delve deeper into the burdens of using paper source forms, and their impact on resources and trial execution at study sites.
| advertisment
A New Paradigm: Cutting-edge Processes and Analytics in Site and Patient Selection
On Demand
 Learn more |
A report from the National Academies of Sciences, Engineering and Medicine proposes FDA shift from a product-specific approach for developing opioids and other pain medications to strategies that more explicitly incorporate public health considerations into opioid-related research and development decisions.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
